nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxyurea—RRM2—Gemcitabine—kidney cancer	0.313	0.44	CbGbCtD
Hydroxyurea—RRM1—Gemcitabine—kidney cancer	0.313	0.44	CbGbCtD
Hydroxyurea—CYP2D6—Temsirolimus—kidney cancer	0.0317	0.0446	CbGbCtD
Hydroxyurea—CYP2D6—Pazopanib—kidney cancer	0.0167	0.0234	CbGbCtD
Hydroxyurea—CYP2D6—Erlotinib—kidney cancer	0.0119	0.0167	CbGbCtD
Hydroxyurea—CYP2D6—Sorafenib—kidney cancer	0.00967	0.0136	CbGbCtD
Hydroxyurea—CYP2D6—Vinblastine—kidney cancer	0.00955	0.0134	CbGbCtD
Hydroxyurea—CYP2D6—Doxorubicin—kidney cancer	0.00587	0.00825	CbGbCtD
Hydroxyurea—RRM1—Fluoropyrimidine Activity—PPAT—kidney cancer	0.00385	0.0722	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—HLTF—kidney cancer	0.00338	0.0633	CbGpPWpGaD
Hydroxyurea—RRM2—Fluoropyrimidine Activity—PPAT—kidney cancer	0.00317	0.0595	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—HLTF—kidney cancer	0.00278	0.0521	CbGpPWpGaD
Hydroxyurea—CYP2D6—urine—kidney cancer	0.00252	0.11	CbGeAlD
Hydroxyurea—RRM2—renal system—kidney cancer	0.00249	0.109	CbGeAlD
Hydroxyurea—RRM2—kidney—kidney cancer	0.00241	0.105	CbGeAlD
Hydroxyurea—RRM1—nephron tubule—kidney cancer	0.00228	0.0996	CbGeAlD
Hydroxyurea—RRM2—gonad—kidney cancer	0.00224	0.0977	CbGeAlD
Hydroxyurea—RRM1—E2F transcription factor network—TFE3—kidney cancer	0.00213	0.0399	CbGpPWpGaD
Hydroxyurea—RRM1—renal system—kidney cancer	0.00207	0.0905	CbGeAlD
Hydroxyurea—RRM1—kidney—kidney cancer	0.002	0.0875	CbGeAlD
Hydroxyurea—RRM1—cortex of kidney—kidney cancer	0.00195	0.0852	CbGeAlD
Hydroxyurea—RRM1—Nucleotide metabolism—PPAT—kidney cancer	0.00194	0.0363	CbGpPWpGaD
Hydroxyurea—RRM1—gonad—kidney cancer	0.00186	0.0812	CbGeAlD
Hydroxyurea—RRM1—cardiac atrium—kidney cancer	0.00186	0.0811	CbGeAlD
Hydroxyurea—RRM1—Nucleotide metabolism—APRT—kidney cancer	0.0018	0.0337	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—TFE3—kidney cancer	0.00175	0.0329	CbGpPWpGaD
Hydroxyurea—RRM2—Nucleotide metabolism—PPAT—kidney cancer	0.00159	0.0299	CbGpPWpGaD
Hydroxyurea—RRM2—Nucleotide metabolism—APRT—kidney cancer	0.00148	0.0278	CbGpPWpGaD
Hydroxyurea—RRM2—Gefitinib—Erlotinib—kidney cancer	0.00144	0.329	CbGdCrCtD
Hydroxyurea—RRM1—E2F transcription factor network—APAF1—kidney cancer	0.00115	0.0215	CbGpPWpGaD
Hydroxyurea—RRM2—Vinorelbine—Vincristine—kidney cancer	0.000963	0.22	CbGdCrCtD
Hydroxyurea—RRM2—Vinorelbine—Vinblastine—kidney cancer	0.000963	0.22	CbGdCrCtD
Hydroxyurea—RRM2—E2F transcription factor network—APAF1—kidney cancer	0.000947	0.0177	CbGpPWpGaD
Hydroxyurea—CYP2D6—Fatty Acid Omega Oxidation—ALDH1A1—kidney cancer	0.000853	0.016	CbGpPWpGaD
Hydroxyurea—RRM1—Azacitidine—Gemcitabine—kidney cancer	0.000618	0.141	CbGdCrCtD
Hydroxyurea—CYP2D6—renal system—kidney cancer	0.000615	0.0269	CbGeAlD
Hydroxyurea—CYP2D6—kidney—kidney cancer	0.000595	0.026	CbGeAlD
Hydroxyurea—CYP2D6—Codeine and Morphine Metabolism—ABCB1—kidney cancer	0.000573	0.0107	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—JUND—kidney cancer	0.000533	0.00998	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—APAF1—kidney cancer	0.000533	0.00998	CbGpPWpGaD
Hydroxyurea—RRM2—G1/S Transition—PSMD7—kidney cancer	0.000521	0.00976	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—WT1—kidney cancer	0.000505	0.00946	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—SYNE2—kidney cancer	0.000487	0.00911	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—ACHE—kidney cancer	0.000439	0.00823	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—PSMD7—kidney cancer	0.000439	0.00822	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—ANXA1—kidney cancer	0.000404	0.00757	CbGpPWpGaD
Hydroxyurea—RRM2—Azacitidine—Gemcitabine—kidney cancer	0.000388	0.0888	CbGdCrCtD
Hydroxyurea—RRM1—Fluoropyrimidine Activity—TP53—kidney cancer	0.000383	0.00717	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—CDKN2A—kidney cancer	0.000364	0.00683	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	0.000363	0.00679	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	0.000363	0.00679	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	0.000339	0.00635	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—CDKN1B—kidney cancer	0.000323	0.00604	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CDKN2B—kidney cancer	0.000321	0.00601	CbGpPWpGaD
Hydroxyurea—RRM2—Fluoropyrimidine Activity—TP53—kidney cancer	0.000315	0.0059	CbGpPWpGaD
Hydroxyurea—CYP2D6—Melatonin metabolism and effects—ACHE—kidney cancer	0.000311	0.00584	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—RAF1—kidney cancer	0.000306	0.00573	CbGpPWpGaD
Hydroxyurea—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—kidney cancer	0.000303	0.00567	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—CDKN2A—kidney cancer	0.0003	0.00562	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	0.000298	0.00558	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	0.000295	0.00553	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—ABCB1—kidney cancer	0.000288	0.0054	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—CDKN1B—kidney cancer	0.00028	0.00525	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—CCND1—kidney cancer	0.000267	0.00501	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—CDKN1B—kidney cancer	0.000266	0.00498	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—ACY1—kidney cancer	0.000254	0.00476	CbGpPWpGaD
Hydroxyurea—CYP2D6—Xenobiotics—CYP1A1—kidney cancer	0.000253	0.00474	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—RAF1—kidney cancer	0.000252	0.00472	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—MYC—kidney cancer	0.000247	0.00463	CbGpPWpGaD
Hydroxyurea—CYP2D6—Tamoxifen metabolism—CYP1A1—kidney cancer	0.000244	0.00456	CbGpPWpGaD
Hydroxyurea—CYP2D6—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.00024	0.0045	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—ACY1—kidney cancer	0.000233	0.00436	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—CDKN1B—kidney cancer	0.000231	0.00433	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—CCND1—kidney cancer	0.00022	0.00413	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PDHB—kidney cancer	0.000216	0.00404	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—MYC—kidney cancer	0.000215	0.00402	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—ACY1—kidney cancer	0.000209	0.00392	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	0.000208	0.00389	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—MYC—kidney cancer	0.000203	0.00381	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CCBL1—kidney cancer	0.000203	0.0038	CbGpPWpGaD
Hydroxyurea—RRM2—G1/S Transition—CDKN1B—kidney cancer	0.000193	0.00361	CbGpPWpGaD
Hydroxyurea—CYP2D6—Melatonin metabolism and effects—CYP1A1—kidney cancer	0.000188	0.00352	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CDKN2A—kidney cancer	0.000183	0.00344	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PDHB—kidney cancer	0.000178	0.00333	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—MYC—kidney cancer	0.000177	0.00331	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—TP53—kidney cancer	0.000176	0.0033	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GLIPR1—kidney cancer	0.000176	0.0033	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PPAT—kidney cancer	0.000176	0.0033	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CCBL1—kidney cancer	0.000167	0.00313	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—APRT—kidney cancer	0.000164	0.00306	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—FH—kidney cancer	0.000164	0.00306	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	0.000163	0.00306	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CDKN1B—kidney cancer	0.000162	0.00304	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	0.000161	0.00302	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—PSMD7—kidney cancer	0.000161	0.00302	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	0.000158	0.00296	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—AURKA—kidney cancer	0.000157	0.00293	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CCND1—kidney cancer	0.000155	0.0029	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GPC3—kidney cancer	0.000154	0.00288	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CA2—kidney cancer	0.00015	0.0028	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	0.000149	0.0028	CbGpPWpGaD
Hydroxyurea—RRM2—G1/S Transition—MYC—kidney cancer	0.000148	0.00276	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—ALAD—kidney cancer	0.000146	0.00273	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—TP53—kidney cancer	0.000145	0.00272	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PPAT—kidney cancer	0.000145	0.00271	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GLIPR1—kidney cancer	0.000145	0.00271	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—PSMD7—kidney cancer	0.000144	0.0027	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	0.000143	0.00267	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—ST3GAL2—kidney cancer	0.000142	0.00267	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	0.000142	0.00267	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	0.000141	0.00265	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—AURKA—kidney cancer	0.00014	0.00262	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—ALDH1A1—kidney cancer	0.000139	0.00261	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	0.000138	0.00258	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—APRT—kidney cancer	0.000135	0.00252	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—FH—kidney cancer	0.000135	0.00252	CbGpPWpGaD
Hydroxyurea—Anorexia—Dactinomycin—kidney cancer	0.000134	0.000641	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—PGK1—kidney cancer	0.000133	0.0025	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—SLC5A3—kidney cancer	0.000133	0.0025	CbGpPWpGaD
Hydroxyurea—Nausea—Pazopanib—kidney cancer	0.000133	0.00064	CcSEcCtD
Hydroxyurea—Neoplasm—Doxorubicin—kidney cancer	0.000133	0.00064	CcSEcCtD
Hydroxyurea—Convulsion—Vincristine—kidney cancer	0.000133	0.000638	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000133	0.000638	CcSEcCtD
Hydroxyurea—Fatigue—Sorafenib—kidney cancer	0.000133	0.000637	CcSEcCtD
Hydroxyurea—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.000132	0.00248	CbGpPWpGaD
Hydroxyurea—Dyspnoea—Sunitinib—kidney cancer	0.000132	0.000634	CcSEcCtD
Hydroxyurea—Pain—Sorafenib—kidney cancer	0.000132	0.000632	CcSEcCtD
Hydroxyurea—Constipation—Sorafenib—kidney cancer	0.000132	0.000632	CcSEcCtD
Hydroxyurea—Malaise—Gemcitabine—kidney cancer	0.000131	0.00063	CcSEcCtD
Hydroxyurea—Pulmonary oedema—Doxorubicin—kidney cancer	0.000131	0.00063	CcSEcCtD
Hydroxyurea—Hypersensitivity—Vinblastine—kidney cancer	0.000131	0.000629	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—LDHB—kidney cancer	0.000131	0.00245	CbGpPWpGaD
Hydroxyurea—Weight increased—Capecitabine—kidney cancer	0.000131	0.000627	CcSEcCtD
Hydroxyurea—Hypersensitivity—Everolimus—kidney cancer	0.000131	0.000627	CcSEcCtD
Hydroxyurea—Dyspepsia—Sunitinib—kidney cancer	0.00013	0.000626	CcSEcCtD
Hydroxyurea—Leukopenia—Gemcitabine—kidney cancer	0.00013	0.000625	CcSEcCtD
Hydroxyurea—Decreased appetite—Sunitinib—kidney cancer	0.000129	0.000618	CcSEcCtD
Hydroxyurea—Infestation—Capecitabine—kidney cancer	0.000128	0.000614	CcSEcCtD
Hydroxyurea—Infestation NOS—Capecitabine—kidney cancer	0.000128	0.000614	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000128	0.000614	CcSEcCtD
Hydroxyurea—Asthenia—Vinblastine—kidney cancer	0.000128	0.000613	CcSEcCtD
Hydroxyurea—Fatigue—Sunitinib—kidney cancer	0.000128	0.000613	CcSEcCtD
Hydroxyurea—CYP2D6—Biological oxidations—ALDH1A1—kidney cancer	0.000128	0.00239	CbGpPWpGaD
Hydroxyurea—Asthenia—Everolimus—kidney cancer	0.000127	0.00061	CcSEcCtD
Hydroxyurea—Angiopathy—Paclitaxel—kidney cancer	0.000127	0.00061	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—GPC3—kidney cancer	0.000127	0.00237	CbGpPWpGaD
Hydroxyurea—Pain—Sunitinib—kidney cancer	0.000127	0.000608	CcSEcCtD
Hydroxyurea—Constipation—Sunitinib—kidney cancer	0.000127	0.000608	CcSEcCtD
Hydroxyurea—Chills—Paclitaxel—kidney cancer	0.000126	0.000603	CcSEcCtD
Hydroxyurea—Neuropathy peripheral—Capecitabine—kidney cancer	0.000125	0.000602	CcSEcCtD
Hydroxyurea—Oedema—Vincristine—kidney cancer	0.000125	0.000601	CcSEcCtD
Hydroxyurea—Stomatitis—Capecitabine—kidney cancer	0.000125	0.000599	CcSEcCtD
Hydroxyurea—Infection—Vincristine—kidney cancer	0.000124	0.000597	CcSEcCtD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—MYC—kidney cancer	0.000124	0.00233	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	0.000124	0.00233	CbGpPWpGaD
Hydroxyurea—Alopecia—Paclitaxel—kidney cancer	0.000124	0.000594	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—CA2—kidney cancer	0.000123	0.00231	CbGpPWpGaD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000123	0.000591	CcSEcCtD
Hydroxyurea—Nervous system disorder—Vincristine—kidney cancer	0.000123	0.00059	CcSEcCtD
Hydroxyurea—Asthenia—Erlotinib—kidney cancer	0.000123	0.000589	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Vincristine—kidney cancer	0.000123	0.000589	CcSEcCtD
Hydroxyurea—Discomfort—Gemcitabine—kidney cancer	0.000122	0.000588	CcSEcCtD
Hydroxyurea—Erythema—Paclitaxel—kidney cancer	0.000122	0.000585	CcSEcCtD
Hydroxyurea—Decreased appetite—Dactinomycin—kidney cancer	0.000122	0.000585	CcSEcCtD
Hydroxyurea—Diarrhoea—Vinblastine—kidney cancer	0.000122	0.000584	CcSEcCtD
Hydroxyurea—Body temperature increased—Sorafenib—kidney cancer	0.000122	0.000584	CcSEcCtD
Hydroxyurea—Diarrhoea—Everolimus—kidney cancer	0.000121	0.000582	CcSEcCtD
Hydroxyurea—Hepatobiliary disease—Capecitabine—kidney cancer	0.000121	0.000581	CcSEcCtD
Hydroxyurea—Fatigue—Dactinomycin—kidney cancer	0.000121	0.00058	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—ALAD—kidney cancer	0.00012	0.00225	CbGpPWpGaD
Hydroxyurea—Pain—Dactinomycin—kidney cancer	0.00012	0.000575	CcSEcCtD
Hydroxyurea—Anorexia—Vincristine—kidney cancer	0.000119	0.000573	CcSEcCtD
Hydroxyurea—Hepatic failure—Doxorubicin—kidney cancer	0.000119	0.000572	CcSEcCtD
Hydroxyurea—Oedema—Gemcitabine—kidney cancer	0.000119	0.00057	CcSEcCtD
Hydroxyurea—Infection—Gemcitabine—kidney cancer	0.000118	0.000567	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDKN2B—kidney cancer	0.000118	0.0022	CbGpPWpGaD
Hydroxyurea—Dizziness—Vinblastine—kidney cancer	0.000118	0.000565	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	0.000118	0.0022	CbGpPWpGaD
Hydroxyurea—Dizziness—Everolimus—kidney cancer	0.000117	0.000563	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—ST3GAL2—kidney cancer	0.000117	0.0022	CbGpPWpGaD
Hydroxyurea—Body temperature increased—Sunitinib—kidney cancer	0.000117	0.000562	CcSEcCtD
Hydroxyurea—Diarrhoea—Erlotinib—kidney cancer	0.000117	0.000562	CcSEcCtD
Hydroxyurea—Nervous system disorder—Gemcitabine—kidney cancer	0.000116	0.000559	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Gemcitabine—kidney cancer	0.000116	0.000558	CcSEcCtD
Hydroxyurea—Renal failure acute—Doxorubicin—kidney cancer	0.000116	0.000557	CcSEcCtD
Hydroxyurea—Feeling abnormal—Dactinomycin—kidney cancer	0.000115	0.000554	CcSEcCtD
Hydroxyurea—Haemoglobin—Capecitabine—kidney cancer	0.000115	0.000554	CcSEcCtD
Hydroxyurea—Skin disorder—Gemcitabine—kidney cancer	0.000115	0.000554	CcSEcCtD
Hydroxyurea—Haemorrhage—Capecitabine—kidney cancer	0.000115	0.000552	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—ALDH1A1—kidney cancer	0.000115	0.00215	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	0.000114	0.00214	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CA9—kidney cancer	0.000113	0.00212	CbGpPWpGaD
Hydroxyurea—Hypersensitivity—Sorafenib—kidney cancer	0.000113	0.000544	CcSEcCtD
Hydroxyurea—Anorexia—Gemcitabine—kidney cancer	0.000113	0.000544	CcSEcCtD
Hydroxyurea—Vomiting—Vinblastine—kidney cancer	0.000113	0.000543	CcSEcCtD
Hydroxyurea—Dizziness—Erlotinib—kidney cancer	0.000113	0.000543	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Paclitaxel—kidney cancer	0.000113	0.000543	CcSEcCtD
Hydroxyurea—Vomiting—Everolimus—kidney cancer	0.000113	0.000541	CcSEcCtD
Hydroxyurea—Anaemia—Paclitaxel—kidney cancer	0.000113	0.000541	CcSEcCtD
Hydroxyurea—Dermatitis bullous—Doxorubicin—kidney cancer	0.000112	0.000538	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	0.000112	0.0021	CbGpPWpGaD
Hydroxyurea—Rash—Everolimus—kidney cancer	0.000112	0.000536	CcSEcCtD
Hydroxyurea—Dermatitis—Everolimus—kidney cancer	0.000112	0.000536	CcSEcCtD
Hydroxyurea—Headache—Vinblastine—kidney cancer	0.000111	0.000535	CcSEcCtD
Hydroxyurea—Headache—Everolimus—kidney cancer	0.000111	0.000533	CcSEcCtD
Hydroxyurea—Body temperature increased—Dactinomycin—kidney cancer	0.000111	0.000532	CcSEcCtD
Hydroxyurea—Asthenia—Sorafenib—kidney cancer	0.00011	0.00053	CcSEcCtD
Hydroxyurea—Malaise—Paclitaxel—kidney cancer	0.00011	0.000528	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—SLC5A3—kidney cancer	0.00011	0.00206	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PGK1—kidney cancer	0.00011	0.00206	CbGpPWpGaD
Hydroxyurea—Leukopenia—Paclitaxel—kidney cancer	0.000109	0.000524	CcSEcCtD
Hydroxyurea—Hypersensitivity—Sunitinib—kidney cancer	0.000109	0.000524	CcSEcCtD
Hydroxyurea—Decreased appetite—Vincristine—kidney cancer	0.000109	0.000523	CcSEcCtD
Hydroxyurea—Vomiting—Erlotinib—kidney cancer	0.000109	0.000522	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Vincristine—kidney cancer	0.000108	0.000519	CcSEcCtD
Hydroxyurea—Fatigue—Vincristine—kidney cancer	0.000108	0.000518	CcSEcCtD
Hydroxyurea—Rash—Erlotinib—kidney cancer	0.000108	0.000518	CcSEcCtD
Hydroxyurea—Dermatitis—Erlotinib—kidney cancer	0.000108	0.000517	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—LDHB—kidney cancer	0.000108	0.00202	CbGpPWpGaD
Hydroxyurea—Headache—Erlotinib—kidney cancer	0.000107	0.000514	CcSEcCtD
Hydroxyurea—Pain—Vincristine—kidney cancer	0.000107	0.000514	CcSEcCtD
Hydroxyurea—Constipation—Vincristine—kidney cancer	0.000107	0.000514	CcSEcCtD
Hydroxyurea—Asthenia—Sunitinib—kidney cancer	0.000106	0.00051	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—BRCA2—kidney cancer	0.000106	0.00199	CbGpPWpGaD
Hydroxyurea—Dyspnoea—Gemcitabine—kidney cancer	0.000106	0.000508	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	0.000106	0.00198	CbGpPWpGaD
Hydroxyurea—Nausea—Vinblastine—kidney cancer	0.000106	0.000507	CcSEcCtD
Hydroxyurea—Somnolence—Gemcitabine—kidney cancer	0.000106	0.000507	CcSEcCtD
Hydroxyurea—Convulsion—Paclitaxel—kidney cancer	0.000106	0.000507	CcSEcCtD
Hydroxyurea—Nausea—Everolimus—kidney cancer	0.000105	0.000505	CcSEcCtD
Hydroxyurea—Diarrhoea—Sorafenib—kidney cancer	0.000105	0.000505	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—CDKN2B—kidney cancer	0.000105	0.00197	CbGpPWpGaD
Hydroxyurea—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000105	0.00197	CbGpPWpGaD
Hydroxyurea—Angiopathy—Capecitabine—kidney cancer	0.000104	0.0005	CcSEcCtD
Hydroxyurea—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.000104	0.00194	CbGpPWpGaD
Hydroxyurea—Face oedema—Doxorubicin—kidney cancer	0.000103	0.000496	CcSEcCtD
Hydroxyurea—Decreased appetite—Gemcitabine—kidney cancer	0.000103	0.000496	CcSEcCtD
Hydroxyurea—Hypersensitivity—Dactinomycin—kidney cancer	0.000103	0.000496	CcSEcCtD
Hydroxyurea—Chills—Capecitabine—kidney cancer	0.000103	0.000495	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000103	0.000495	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000103	0.000492	CcSEcCtD
Hydroxyurea—Discomfort—Paclitaxel—kidney cancer	0.000102	0.000492	CcSEcCtD
Hydroxyurea—Fatigue—Gemcitabine—kidney cancer	0.000102	0.000492	CcSEcCtD
Hydroxyurea—Dizziness—Sorafenib—kidney cancer	0.000102	0.000488	CcSEcCtD
Hydroxyurea—Pain—Gemcitabine—kidney cancer	0.000102	0.000488	CcSEcCtD
Hydroxyurea—Constipation—Gemcitabine—kidney cancer	0.000102	0.000488	CcSEcCtD
Hydroxyurea—Nausea—Erlotinib—kidney cancer	0.000102	0.000488	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—BIRC5—kidney cancer	0.000102	0.0019	CbGpPWpGaD
Hydroxyurea—Alopecia—Capecitabine—kidney cancer	0.000101	0.000487	CcSEcCtD
Hydroxyurea—Diarrhoea—Sunitinib—kidney cancer	0.000101	0.000486	CcSEcCtD
Hydroxyurea—Asthenia—Dactinomycin—kidney cancer	0.000101	0.000483	CcSEcCtD
Hydroxyurea—Blood creatinine increased—Doxorubicin—kidney cancer	0.0001	0.000481	CcSEcCtD
Hydroxyurea—Erythema—Capecitabine—kidney cancer	0.0001	0.00048	CcSEcCtD
Hydroxyurea—Oedema—Paclitaxel—kidney cancer	9.94e-05	0.000477	CcSEcCtD
Hydroxyurea—Body temperature increased—Vincristine—kidney cancer	9.9e-05	0.000475	CcSEcCtD
Hydroxyurea—Infection—Paclitaxel—kidney cancer	9.88e-05	0.000474	CcSEcCtD
Hydroxyurea—Dizziness—Sunitinib—kidney cancer	9.79e-05	0.00047	CcSEcCtD
Hydroxyurea—Feeling abnormal—Gemcitabine—kidney cancer	9.79e-05	0.00047	CcSEcCtD
Hydroxyurea—Vomiting—Sorafenib—kidney cancer	9.78e-05	0.00047	CcSEcCtD
Hydroxyurea—Nervous system disorder—Paclitaxel—kidney cancer	9.75e-05	0.000468	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Paclitaxel—kidney cancer	9.74e-05	0.000467	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	9.71e-05	0.00182	CbGpPWpGaD
Hydroxyurea—Rash—Sorafenib—kidney cancer	9.7e-05	0.000466	CcSEcCtD
Hydroxyurea—Dermatitis—Sorafenib—kidney cancer	9.69e-05	0.000465	CcSEcCtD
Hydroxyurea—Breast disorder—Doxorubicin—kidney cancer	9.67e-05	0.000464	CcSEcCtD
Hydroxyurea—Skin disorder—Paclitaxel—kidney cancer	9.66e-05	0.000464	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—CRABP1—kidney cancer	9.64e-05	0.00181	CbGpPWpGaD
Hydroxyurea—Headache—Sorafenib—kidney cancer	9.64e-05	0.000463	CcSEcCtD
Hydroxyurea—Diarrhoea—Dactinomycin—kidney cancer	9.59e-05	0.00046	CcSEcCtD
Hydroxyurea—Anorexia—Paclitaxel—kidney cancer	9.48e-05	0.000455	CcSEcCtD
Hydroxyurea—Vomiting—Sunitinib—kidney cancer	9.41e-05	0.000452	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	9.39e-05	0.00176	CbGpPWpGaD
Hydroxyurea—Body temperature increased—Gemcitabine—kidney cancer	9.39e-05	0.000451	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—CA9—kidney cancer	9.34e-05	0.00175	CbGpPWpGaD
Hydroxyurea—Rash—Sunitinib—kidney cancer	9.33e-05	0.000448	CcSEcCtD
Hydroxyurea—Dermatitis—Sunitinib—kidney cancer	9.32e-05	0.000448	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Capecitabine—kidney cancer	9.28e-05	0.000445	CcSEcCtD
Hydroxyurea—Headache—Sunitinib—kidney cancer	9.27e-05	0.000445	CcSEcCtD
Hydroxyurea—Anaemia—Capecitabine—kidney cancer	9.24e-05	0.000444	CcSEcCtD
Hydroxyurea—Hypersensitivity—Vincristine—kidney cancer	9.22e-05	0.000443	CcSEcCtD
Hydroxyurea—Nausea—Sorafenib—kidney cancer	9.14e-05	0.000439	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—BIRC5—kidney cancer	9.08e-05	0.0017	CbGpPWpGaD
Hydroxyurea—Pancreatitis—Doxorubicin—kidney cancer	9.07e-05	0.000435	CcSEcCtD
Hydroxyurea—Malaise—Capecitabine—kidney cancer	9.02e-05	0.000433	CcSEcCtD
Hydroxyurea—Asthenia—Vincristine—kidney cancer	8.98e-05	0.000431	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—ITPR2—kidney cancer	8.96e-05	0.00168	CbGpPWpGaD
Hydroxyurea—Leukopenia—Capecitabine—kidney cancer	8.95e-05	0.00043	CcSEcCtD
Hydroxyurea—Vomiting—Dactinomycin—kidney cancer	8.91e-05	0.000428	CcSEcCtD
Hydroxyurea—Dyspnoea—Paclitaxel—kidney cancer	8.86e-05	0.000426	CcSEcCtD
Hydroxyurea—Somnolence—Paclitaxel—kidney cancer	8.84e-05	0.000424	CcSEcCtD
Hydroxyurea—Rash—Dactinomycin—kidney cancer	8.83e-05	0.000424	CcSEcCtD
Hydroxyurea—Nausea—Sunitinib—kidney cancer	8.79e-05	0.000422	CcSEcCtD
Hydroxyurea—Pancytopenia—Doxorubicin—kidney cancer	8.78e-05	0.000422	CcSEcCtD
Hydroxyurea—Dyspepsia—Paclitaxel—kidney cancer	8.75e-05	0.00042	CcSEcCtD
Hydroxyurea—Neutropenia—Doxorubicin—kidney cancer	8.65e-05	0.000415	CcSEcCtD
Hydroxyurea—Dysuria—Doxorubicin—kidney cancer	8.65e-05	0.000415	CcSEcCtD
Hydroxyurea—Decreased appetite—Paclitaxel—kidney cancer	8.64e-05	0.000415	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Paclitaxel—kidney cancer	8.58e-05	0.000412	CcSEcCtD
Hydroxyurea—Fatigue—Paclitaxel—kidney cancer	8.57e-05	0.000412	CcSEcCtD
Hydroxyurea—Diarrhoea—Vincristine—kidney cancer	8.57e-05	0.000411	CcSEcCtD
Hydroxyurea—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	8.52e-05	0.0016	CbGpPWpGaD
Hydroxyurea—Asthenia—Gemcitabine—kidney cancer	8.52e-05	0.000409	CcSEcCtD
Hydroxyurea—Constipation—Paclitaxel—kidney cancer	8.5e-05	0.000408	CcSEcCtD
Hydroxyurea—Pain—Paclitaxel—kidney cancer	8.5e-05	0.000408	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	8.45e-05	0.000406	CcSEcCtD
Hydroxyurea—Weight increased—Doxorubicin—kidney cancer	8.42e-05	0.000404	CcSEcCtD
Hydroxyurea—Discomfort—Capecitabine—kidney cancer	8.41e-05	0.000404	CcSEcCtD
Hydroxyurea—Nausea—Dactinomycin—kidney cancer	8.32e-05	0.0004	CcSEcCtD
Hydroxyurea—Dizziness—Vincristine—kidney cancer	8.28e-05	0.000398	CcSEcCtD
Hydroxyurea—Drowsiness—Doxorubicin—kidney cancer	8.25e-05	0.000396	CcSEcCtD
Hydroxyurea—Infestation NOS—Doxorubicin—kidney cancer	8.25e-05	0.000396	CcSEcCtD
Hydroxyurea—Infestation—Doxorubicin—kidney cancer	8.25e-05	0.000396	CcSEcCtD
Hydroxyurea—Feeling abnormal—Paclitaxel—kidney cancer	8.19e-05	0.000393	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—ACHE—kidney cancer	8.17e-05	0.00153	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GSTT1—kidney cancer	8.17e-05	0.00153	CbGpPWpGaD
Hydroxyurea—Oedema—Capecitabine—kidney cancer	8.16e-05	0.000392	CcSEcCtD
Hydroxyurea—Diarrhoea—Gemcitabine—kidney cancer	8.13e-05	0.00039	CcSEcCtD
Hydroxyurea—Infection—Capecitabine—kidney cancer	8.11e-05	0.000389	CcSEcCtD
Hydroxyurea—Neuropathy peripheral—Doxorubicin—kidney cancer	8.08e-05	0.000388	CcSEcCtD
Hydroxyurea—Stomatitis—Doxorubicin—kidney cancer	8.04e-05	0.000386	CcSEcCtD
Hydroxyurea—Nervous system disorder—Capecitabine—kidney cancer	8e-05	0.000384	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Capecitabine—kidney cancer	7.99e-05	0.000384	CcSEcCtD
Hydroxyurea—Vomiting—Vincristine—kidney cancer	7.96e-05	0.000382	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—CRABP1—kidney cancer	7.94e-05	0.00149	CbGpPWpGaD
Hydroxyurea—Skin disorder—Capecitabine—kidney cancer	7.93e-05	0.000381	CcSEcCtD
Hydroxyurea—Rash—Vincristine—kidney cancer	7.89e-05	0.000379	CcSEcCtD
Hydroxyurea—Dermatitis—Vincristine—kidney cancer	7.89e-05	0.000379	CcSEcCtD
Hydroxyurea—Body temperature increased—Paclitaxel—kidney cancer	7.86e-05	0.000377	CcSEcCtD
Hydroxyurea—Headache—Vincristine—kidney cancer	7.84e-05	0.000377	CcSEcCtD
Hydroxyurea—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	7.84e-05	0.00147	CbGpPWpGaD
Hydroxyurea—Hepatobiliary disease—Doxorubicin—kidney cancer	7.8e-05	0.000375	CcSEcCtD
Hydroxyurea—Anorexia—Capecitabine—kidney cancer	7.78e-05	0.000373	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—SCARB1—kidney cancer	7.74e-05	0.00145	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PTGS1—kidney cancer	7.66e-05	0.00143	CbGpPWpGaD
Hydroxyurea—Vomiting—Gemcitabine—kidney cancer	7.55e-05	0.000363	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—PSMD7—kidney cancer	7.51e-05	0.00141	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—GSTT1—kidney cancer	7.5e-05	0.0014	CbGpPWpGaD
Hydroxyurea—Rash—Gemcitabine—kidney cancer	7.49e-05	0.00036	CcSEcCtD
Hydroxyurea—Dermatitis—Gemcitabine—kidney cancer	7.48e-05	0.000359	CcSEcCtD
Hydroxyurea—Haemoglobin—Doxorubicin—kidney cancer	7.44e-05	0.000357	CcSEcCtD
Hydroxyurea—Headache—Gemcitabine—kidney cancer	7.44e-05	0.000357	CcSEcCtD
Hydroxyurea—Nausea—Vincristine—kidney cancer	7.44e-05	0.000357	CcSEcCtD
Hydroxyurea—Haemorrhage—Doxorubicin—kidney cancer	7.4e-05	0.000356	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—ITPR2—kidney cancer	7.38e-05	0.00138	CbGpPWpGaD
Hydroxyurea—Hypersensitivity—Paclitaxel—kidney cancer	7.33e-05	0.000352	CcSEcCtD
Hydroxyurea—Dyspnoea—Capecitabine—kidney cancer	7.27e-05	0.000349	CcSEcCtD
Hydroxyurea—Dyspepsia—Capecitabine—kidney cancer	7.18e-05	0.000345	CcSEcCtD
Hydroxyurea—Asthenia—Paclitaxel—kidney cancer	7.13e-05	0.000343	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—BCHE—kidney cancer	7.12e-05	0.00133	CbGpPWpGaD
Hydroxyurea—Decreased appetite—Capecitabine—kidney cancer	7.09e-05	0.000341	CcSEcCtD
Hydroxyurea—Nausea—Gemcitabine—kidney cancer	7.05e-05	0.000339	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Capecitabine—kidney cancer	7.04e-05	0.000338	CcSEcCtD
Hydroxyurea—Fatigue—Capecitabine—kidney cancer	7.03e-05	0.000338	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—SLC5A5—kidney cancer	7.03e-05	0.00132	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—PTGS1—kidney cancer	7.03e-05	0.00132	CbGpPWpGaD
Hydroxyurea—Pain—Capecitabine—kidney cancer	6.98e-05	0.000335	CcSEcCtD
Hydroxyurea—Constipation—Capecitabine—kidney cancer	6.98e-05	0.000335	CcSEcCtD
Hydroxyurea—Diarrhoea—Paclitaxel—kidney cancer	6.8e-05	0.000327	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—SLC2A1—kidney cancer	6.79e-05	0.00127	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—ACHE—kidney cancer	6.73e-05	0.00126	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GSTT1—kidney cancer	6.73e-05	0.00126	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDKN2A—kidney cancer	6.73e-05	0.00126	CbGpPWpGaD
Hydroxyurea—Feeling abnormal—Capecitabine—kidney cancer	6.72e-05	0.000323	CcSEcCtD
Hydroxyurea—Angiopathy—Doxorubicin—kidney cancer	6.72e-05	0.000323	CcSEcCtD
Hydroxyurea—Chills—Doxorubicin—kidney cancer	6.64e-05	0.000319	CcSEcCtD
Hydroxyurea—Dizziness—Paclitaxel—kidney cancer	6.58e-05	0.000316	CcSEcCtD
Hydroxyurea—Alopecia—Doxorubicin—kidney cancer	6.54e-05	0.000314	CcSEcCtD
Hydroxyurea—Body temperature increased—Capecitabine—kidney cancer	6.45e-05	0.00031	CcSEcCtD
Hydroxyurea—Erythema—Doxorubicin—kidney cancer	6.44e-05	0.000309	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—SCARB1—kidney cancer	6.37e-05	0.00119	CbGpPWpGaD
Hydroxyurea—CYP2D6—Phase 1 - Functionalization of compounds—POMC—kidney cancer	6.35e-05	0.00119	CbGpPWpGaD
Hydroxyurea—Vomiting—Paclitaxel—kidney cancer	6.32e-05	0.000304	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—PTGS1—kidney cancer	6.31e-05	0.00118	CbGpPWpGaD
Hydroxyurea—Rash—Paclitaxel—kidney cancer	6.27e-05	0.000301	CcSEcCtD
Hydroxyurea—Dermatitis—Paclitaxel—kidney cancer	6.26e-05	0.000301	CcSEcCtD
Hydroxyurea—Headache—Paclitaxel—kidney cancer	6.23e-05	0.000299	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—PSMD7—kidney cancer	6.18e-05	0.00116	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—CDKN2A—kidney cancer	6.02e-05	0.00113	CbGpPWpGaD
Hydroxyurea—Hypersensitivity—Capecitabine—kidney cancer	6.01e-05	0.000289	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Doxorubicin—kidney cancer	5.98e-05	0.000287	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDKN1B—kidney cancer	5.96e-05	0.00112	CbGpPWpGaD
Hydroxyurea—Anaemia—Doxorubicin—kidney cancer	5.96e-05	0.000286	CcSEcCtD
Hydroxyurea—Nausea—Paclitaxel—kidney cancer	5.91e-05	0.000284	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—BCHE—kidney cancer	5.86e-05	0.0011	CbGpPWpGaD
Hydroxyurea—Asthenia—Capecitabine—kidney cancer	5.85e-05	0.000281	CcSEcCtD
Hydroxyurea—Malaise—Doxorubicin—kidney cancer	5.81e-05	0.000279	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—SLC5A5—kidney cancer	5.79e-05	0.00108	CbGpPWpGaD
Hydroxyurea—Leukopenia—Doxorubicin—kidney cancer	5.77e-05	0.000277	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CCND1—kidney cancer	5.68e-05	0.00106	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GSTP1—kidney cancer	5.66e-05	0.00106	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—SLC2A1—kidney cancer	5.59e-05	0.00105	CbGpPWpGaD
Hydroxyurea—Convulsion—Doxorubicin—kidney cancer	5.58e-05	0.000268	CcSEcCtD
Hydroxyurea—Diarrhoea—Capecitabine—kidney cancer	5.58e-05	0.000268	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	5.45e-05	0.000262	CcSEcCtD
Hydroxyurea—Discomfort—Doxorubicin—kidney cancer	5.42e-05	0.00026	CcSEcCtD
Hydroxyurea—Dizziness—Capecitabine—kidney cancer	5.4e-05	0.000259	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—ABCB1—kidney cancer	5.36e-05	0.001	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—CDKN1B—kidney cancer	5.33e-05	0.000998	CbGpPWpGaD
Hydroxyurea—Oedema—Doxorubicin—kidney cancer	5.26e-05	0.000253	CcSEcCtD
Hydroxyurea—Infection—Doxorubicin—kidney cancer	5.23e-05	0.000251	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—GSTM1—kidney cancer	5.21e-05	0.000975	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—GSTP1—kidney cancer	5.2e-05	0.000974	CbGpPWpGaD
Hydroxyurea—Vomiting—Capecitabine—kidney cancer	5.19e-05	0.000249	CcSEcCtD
Hydroxyurea—Nervous system disorder—Doxorubicin—kidney cancer	5.16e-05	0.000248	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Doxorubicin—kidney cancer	5.15e-05	0.000247	CcSEcCtD
Hydroxyurea—Rash—Capecitabine—kidney cancer	5.14e-05	0.000247	CcSEcCtD
Hydroxyurea—Dermatitis—Capecitabine—kidney cancer	5.14e-05	0.000247	CcSEcCtD
Hydroxyurea—CYP2D6—Metapathway biotransformation—GSTP1—kidney cancer	5.13e-05	0.00096	CbGpPWpGaD
Hydroxyurea—Headache—Capecitabine—kidney cancer	5.11e-05	0.000245	CcSEcCtD
Hydroxyurea—Skin disorder—Doxorubicin—kidney cancer	5.11e-05	0.000245	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—CCND1—kidney cancer	5.08e-05	0.000952	CbGpPWpGaD
Hydroxyurea—Anorexia—Doxorubicin—kidney cancer	5.01e-05	0.000241	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—CYP1A1—kidney cancer	4.93e-05	0.000925	CbGpPWpGaD
Hydroxyurea—Nausea—Capecitabine—kidney cancer	4.85e-05	0.000233	CcSEcCtD
Hydroxyurea—CYP2D6—Biological oxidations—GSTM1—kidney cancer	4.78e-05	0.000895	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—GSTM1—kidney cancer	4.71e-05	0.000882	CbGpPWpGaD
Hydroxyurea—Dyspnoea—Doxorubicin—kidney cancer	4.69e-05	0.000225	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—MAPK3—kidney cancer	4.69e-05	0.000878	CbGpPWpGaD
Hydroxyurea—Somnolence—Doxorubicin—kidney cancer	4.68e-05	0.000225	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—GSTP1—kidney cancer	4.66e-05	0.000874	CbGpPWpGaD
Hydroxyurea—Dyspepsia—Doxorubicin—kidney cancer	4.63e-05	0.000222	CcSEcCtD
Hydroxyurea—Decreased appetite—Doxorubicin—kidney cancer	4.57e-05	0.00022	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—MYC—kidney cancer	4.56e-05	0.000854	CbGpPWpGaD
Hydroxyurea—Gastrointestinal disorder—Doxorubicin—kidney cancer	4.54e-05	0.000218	CcSEcCtD
Hydroxyurea—Fatigue—Doxorubicin—kidney cancer	4.53e-05	0.000218	CcSEcCtD
Hydroxyurea—CYP2D6—Biological oxidations—CYP1A1—kidney cancer	4.53e-05	0.000848	CbGpPWpGaD
Hydroxyurea—Pain—Doxorubicin—kidney cancer	4.5e-05	0.000216	CcSEcCtD
Hydroxyurea—Constipation—Doxorubicin—kidney cancer	4.5e-05	0.000216	CcSEcCtD
Hydroxyurea—CYP2D6—Metapathway biotransformation—CYP1A1—kidney cancer	4.47e-05	0.000837	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—MAPK1—kidney cancer	4.46e-05	0.000836	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—ABCB1—kidney cancer	4.42e-05	0.000827	CbGpPWpGaD
Hydroxyurea—Feeling abnormal—Doxorubicin—kidney cancer	4.33e-05	0.000208	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—GSTM1—kidney cancer	4.29e-05	0.000803	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—MAPK3—kidney cancer	4.19e-05	0.000785	CbGpPWpGaD
Hydroxyurea—Body temperature increased—Doxorubicin—kidney cancer	4.16e-05	0.0002	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—MYC—kidney cancer	4.08e-05	0.000764	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CYP1A1—kidney cancer	4.06e-05	0.000761	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—MAPK1—kidney cancer	3.99e-05	0.000747	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ACY1—kidney cancer	3.98e-05	0.000746	CbGpPWpGaD
Hydroxyurea—Hypersensitivity—Doxorubicin—kidney cancer	3.88e-05	0.000186	CcSEcCtD
Hydroxyurea—Asthenia—Doxorubicin—kidney cancer	3.77e-05	0.000181	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—POMC—kidney cancer	3.68e-05	0.000689	CbGpPWpGaD
Hydroxyurea—Diarrhoea—Doxorubicin—kidney cancer	3.6e-05	0.000173	CcSEcCtD
Hydroxyurea—Dizziness—Doxorubicin—kidney cancer	3.48e-05	0.000167	CcSEcCtD
Hydroxyurea—CYP2D6—Metabolism—PDHB—kidney cancer	3.39e-05	0.000634	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—POMC—kidney cancer	3.38e-05	0.000632	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—TP53—kidney cancer	3.35e-05	0.000627	CbGpPWpGaD
Hydroxyurea—Vomiting—Doxorubicin—kidney cancer	3.34e-05	0.000161	CcSEcCtD
Hydroxyurea—Rash—Doxorubicin—kidney cancer	3.32e-05	0.000159	CcSEcCtD
Hydroxyurea—Dermatitis—Doxorubicin—kidney cancer	3.31e-05	0.000159	CcSEcCtD
Hydroxyurea—Headache—Doxorubicin—kidney cancer	3.3e-05	0.000158	CcSEcCtD
Hydroxyurea—CYP2D6—Metabolism—CCBL1—kidney cancer	3.18e-05	0.000596	CbGpPWpGaD
Hydroxyurea—Nausea—Doxorubicin—kidney cancer	3.12e-05	0.00015	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—POMC—kidney cancer	3.03e-05	0.000568	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PTGS2—kidney cancer	2.93e-05	0.00055	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GLIPR1—kidney cancer	2.76e-05	0.000517	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PPAT—kidney cancer	2.76e-05	0.000517	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—FH—kidney cancer	2.57e-05	0.000481	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—APRT—kidney cancer	2.57e-05	0.000481	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PTEN—kidney cancer	2.56e-05	0.000479	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PTGS2—kidney cancer	2.42e-05	0.000453	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GPC3—kidney cancer	2.41e-05	0.000452	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CA2—kidney cancer	2.35e-05	0.00044	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ALAD—kidney cancer	2.29e-05	0.000429	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ST3GAL2—kidney cancer	2.23e-05	0.000418	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ALDH1A1—kidney cancer	2.18e-05	0.000409	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PTEN—kidney cancer	2.11e-05	0.000395	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PGK1—kidney cancer	2.09e-05	0.000392	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—SLC5A3—kidney cancer	2.09e-05	0.000392	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—LDHB—kidney cancer	2.05e-05	0.000384	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PIK3CA—kidney cancer	1.81e-05	0.000338	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CA9—kidney cancer	1.78e-05	0.000333	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CRABP1—kidney cancer	1.51e-05	0.000283	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PIK3CA—kidney cancer	1.49e-05	0.000279	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ITPR2—kidney cancer	1.41e-05	0.000263	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ACHE—kidney cancer	1.28e-05	0.00024	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GSTT1—kidney cancer	1.28e-05	0.00024	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—SCARB1—kidney cancer	1.21e-05	0.000227	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PTGS1—kidney cancer	1.2e-05	0.000225	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PSMD7—kidney cancer	1.18e-05	0.000221	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—BCHE—kidney cancer	1.12e-05	0.000209	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—SLC5A5—kidney cancer	1.1e-05	0.000207	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—SLC2A1—kidney cancer	1.07e-05	0.0002	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GSTP1—kidney cancer	8.89e-06	0.000167	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ABCB1—kidney cancer	8.41e-06	0.000158	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GSTM1—kidney cancer	8.17e-06	0.000153	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CYP1A1—kidney cancer	7.74e-06	0.000145	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—POMC—kidney cancer	5.77e-06	0.000108	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PTGS2—kidney cancer	4.6e-06	8.63e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PTEN—kidney cancer	4.02e-06	7.52e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PIK3CA—kidney cancer	2.83e-06	5.31e-05	CbGpPWpGaD
